The Cell and Gene Therapy MSc provides you with an in-depth insight into this cutting-edge and rapidly developing field. The programme is delivered by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques.
Modes and duration
Part-time students will take four modules per year plus the project in year 2. Modules on this programme tend to be taught over a period of a week with intervals between modules.
Tuition fees (2020/21)
Note on fees: The tuition fees shown are for the year indicated above. Fees for subsequent years may increase or otherwise vary. Further information on fee status, fee increases and the fee schedule can be viewed on the UCL Students website. Fees for flexible, modular study are charged pro-rata to the appropriate full-time Master's fee taken in an academic session.
Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MBBS; a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum of three years).
English language requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Good
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
About this degree
The programme covers all aspects of cell and gene therapy, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and complete a practical laboratory-based project.
Students undertake modules to the value of 180 credits.
The programme consists of five compulsory modules (75 credits), three optional modules from a list of six (45 credits) and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months or flexible up to five years) is offered
A Postgraduate Certificate (60 credits, full-time 12 weeks, part-time nine months, or up to two years flexible) is offered.
Upon successful completion of 180 credits, you will be awarded a MSc in Cell and Gene Therapy. Upon successful completion of 120 credits, you will be awarded a PG Dip in Cell and Gene Therapy. Upon successful completion of 60 credits, you will be awarded a PG Cert in Cell and Gene Therapy.
Please note that the list of modules given here is indicative. This information is published a long time in advance of enrolment and module content and availability is subject to change.
- Molecular Aspects of Cell and Gene Therapy
- Clinical Applications of Cell and Gene Therapy
- Applied Statistics for Health Research 1
- Stem Cells and Tissue Repair
- Applied Genomics
- Research Project in Cell and Gene Therapy
Applied Statistics for Health Research 1 is not a compulsory module for the PG Certificate. Students of the PG Certificate can choose an optional module.
Students take 45 credits of optional modules drawn from the list below. It may not be possible to take your preferred optional module because of timetabling and capacity constraints. The list below is subject to change by the time of enrolment. Options may include the following:
- Clinical Genomics Genetic and Rare Diseases
- Molecular Biology of Normal Development and Birth Defects
- Understanding Research and Critical Appraisal: Biomedicine
- Molecular and Clinical Aspects of Childhood Cancers
- Novel Therapies from Concept to Clinic*
- Personalised Medicine*
* Students can take either Personalised Medicine or Novel Therapies from Concept to Clinic as optional module.
All MSc students undertake an independent research project which culminates in a dissertation.
Teaching and learning
Teaching includes lectures, seminars, problem classes and tutorials. Assessment varies depending on the module, but includes written coursework, multiple-choice questions, written examinations, a practical analysis examination and the dissertation of up to 10,000 words
Visit the funding and studentship pages of the GOS ICH website for details of funding available to students, including the GOS ICH bursary.
For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
This programme aims to equip students for careers in research, education, medicine and business in academic, clinical and industrial settings. Examples of potential careers could include:
- conducting clinical trials as part of a team of clinicians, scientists and allied health professionals
- monitoring and analysing the results of clinical trials as part of a clinical trials unit
- developing new therapies or intellectual property in the pharmaceutical industry or other business venture
- academic research and/or lecturing in a university or other higher education setting,
Several of our graduates have gone on to secure PhD places. You can read testimonials from past students which include their destinations following graduation.
Why study this degree at UCL?
The UCL Great Ormond Street Institute of Child Health (UCL GOS ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical, basic research and postgraduate education in children's health, including haematopoietic stem cell transplantation (HSCT) and gene therapy.
The UCL School of Life & Medical Sciences (SLMS) has the largest concentration of clinicians and researchers active in cell and gene therapy research in Europe. This is reflected by the many groups conducting high-quality research and clinical trials in the field including researchers at UCL GOS ICH, the Division of Infection & Immunity, the Institute of Ophthalmology, the Institute for Women's Health, the Institute of Genetics and the Cancer Institute.
Department: Great Ormond Street Institute of Child Health
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
There is an application processing fee for this programme of £80 for online applications and £105 for paper applications. Further information can be found at: www.ucl.ac.uk/prospective-students/graduate/taught/application.
Who can apply?
The programme is designed for medical practitioners and scientists who would like to develop their knowledge in this distinct area, with a view to contributing to research and clinical trials in the field.
- All applicants
- 28 August 2020
For more information see our Applications page.Apply now
What are we looking for?
When we assess your application we would like to learn:
- why you want to study Cell and Gene Therapy at graduate level
- why you want to study Cell and Gene Therapy at UCL
- what particularly attracts you to this programme
- how your academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree
Together with essential academic requirements, the personal statement is your opportunity to illustrate whether your reasons for applying to this programme match what the programme will deliver.
UCL is regulated by the Office for Students.